1.College of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu (611137), China
2.Department of Neurology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu (610072), China
Author bio:
Prof. WU Li-juan, E-mail: wulijuan@cdutcm.edu.cn
Funds:
National Natural Science Foundation of China(82305211);China Postdoctoral Science Foundation(2022MD723716);Sichuan Science and Technology Program(24NSFSC0642);the "Xinglin Scholars" Disciplinary Talent Research Improvement Plan–Youth Fund Talent Program(QJRC2022047);the Post Doctoral Program of Xinglin Scholar Discipline Talent Scientific Research Promotion Program of Chengdu University of Traditional Chinese Medicine(BSH2021029)
To explore the preventive and therapeutic effects of Dahuang Zhechong Pill (DZP) on pulmonary fibrosis and the underlying mechanisms.
Methods:
2
The first key rate-limiting enzyme hexokinase 2 (HK2) of glycolysis was silenced and over-expressed through small interfering RNA and lentivirus using lung fibroblast MRC-5 cell line
respectively. The cell viability
migration
invasion and proliferation were detected by cell counting kit-8
wound healing assay
transwell assay
and flow cytometry. The mRNA and protein expression levels of HK2 were detected by RT-PCR and Western blotting
respectively. The contents of glucose
adenosine triphosphate (ATP) and lactate in MRC-5 cells were determined by enzyme-linked immunosorbnent assay (ELISA). Then
the relationship between miR-29b-2-5p and HK2 was explored by luciferase reporter gene assay. Pulmonary fibrosis cell model was induced by transforming growth factor-β 1 (TGF-β1) in MRC-5 cells
and the medicated serum of DZP (DMS) was prepared in rats. MRC-5 cells were divided into control
TGF-β1
TGF-β1+10% DMS
TGF-β1+10% DMS+miR-29b-2-5p inhibitor
TGF-β1+10% DMS+inhibitor negative control
TGF-β1+10% DMS+miR-29b-2-5p mimic and TGF-β1+10% DMS+mimic negative control groups. After miR-29b-2-5p mimics and inhibitors were transfected into MRC-5 cells
all groups except control and model group were treated with DMS. The effect of DMS on MRC-5 cells were detected using aforementioned methods and immunofluorescence. Similarly
the contents of glucose
ATP and lactate in each group were measured by ELISA.
Results:
2
The mRNA and protein expressions of HK2 in MRC-5 cells were successfully silenced and overexpressed through si-HK2-3 and lentiviral transfection
respectively. After silencing HK2
the mRNA and protein expressions of HK2 were significantly decreased (
P
<
0.01)
and the concentrations of glucose
ATP and lactate were also significantly decreased (
P
<
0.05). The proliferation
migration and invasion of MRC-5 cells were significantly declined (
P
<
0.05 or
P
<
0.01)
while the apoptosis of MRC-5 cells was significantly increased (
P
<
0.01). After overexpressing HK2
the mRNA and protein expressions of HK2 were significantly increased (
P
<
0.05)
and the concentrations of glucose
ATP and lactate were also significantly increased (
P
<
0.05 or
P
<
0.01). The proliferation
migration and invasion of MRC-5 cells were significantly increased (
P
<
0.05 or
P
<
0.01)
while the apoptosis of MRC-5 cells was significantly decreased (
P
<
0.05). The relative luciferase activity of 3'UTR-WT+hsa-miR-29b-2-5p transfected with HK2 was significantly decreased (
P
<
0.01). After miR-29b-2-5p mimic and inhibitor were transfected into the MRC-5 cells
DMS intervention could significantly reduce the concentration of glucose
ATP and lactate
and the mRNA and protein expressions of HK2
phosphofructokinase and pyruvate kinase isoform M2 (
P
<
0.05 or
P
<
0.01). The proliferation
migration and invasion of MRC-5 cells were alleviated (
P
<
0.05 or
P
<
0.01)
and the deposition of fibronectin
α-smooth muscle actin
and collagen Ⅰ were significantly decreased (
P
<
0.05 or
P
<
0.01).
Conclusions:
2
Glycolysis is closely related to pulmonary fibrosis. DZP reduced glycolysis and inhibited fibroblasts' excessive differentiation and abnormal collagen deposition through the miR-29b-2-5p/HK2 pathway
which played a role in delaying the process of pulmonary fibrosis.